US Patent 11903938 Methods of treating Fabry patients having renal impairment
Patent 11903938 was granted and assigned to Amicus Therapeutics on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+50 properties)
Article (+301 characters)
US Patent 11903938 Methods of treating Fabry patients having renal impairment
Article
Patent abstract
Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in α-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Elfrida Benjamin0
Jeff Castelli0
Date of Patent
February 20, 2024
0Patent Application Number
172136320
Date Filed
March 26, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11903938 Methods of treating Fabry patients having renal impairment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
